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2014TheCORE-Homdatabasewas created to answer the need for a reliable and publicly avail-
able source of information in the field of clinical research in homeopathy. As of May 2014
it held 1048 entries of clinical trials, observational studies and surveys in the field of ho-
meopathy, including second publications and re-analyses. 352 of the trials referenced in
the database were published in peer reviewed journals, 198 of which were randomised
controlled trials. The most often used remedies were Arnica montana (n = 103) and
Traumeel (n = 40). The most studied medical conditions were respiratory tract infec-
tions (n = 126) and traumatic injuries (n = 110). The aim of this article is to introduce
the database to the public, describing and explaining the interface, features and content
of the CORE-Hom database. Homeopathy (2014) 103, 219e223.
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In homeopathy, diseases are treated according to the sim-
ilia principle “let like be cured by like” (similia similibus
curentur). This means that a certain drug is selected for
treating a condition (usually in a low dose preparation
called “potency”), which can evoke similar symptoms
when given to healthy volunteers in higher doses. The
low dose preparations are prepared according to a special
procedure which includes serial dilution steps called “suc-
cussion” or “potentisation”. This way of preparation is
thought to be required for the biological action of the rem-
edies through a mechanism as yet not understood. The
number of such dilution steps is not limited and many ho-
meopathic remedies are diluted to such a degree that it is
highly unlikely that a single molecule of the starting mate-
rial is left.
Despite its central role in homeopathy, most of the crit-
icism levelled at homeopathy has not focused on the similia
principle, but on the absence of any active molecule inndence: J€urgen Clausen, Karl und Veronica
-Stiftung, Am Deimelsberg 36, 45276 Essen, Germany.
fo@Carstens-Stiftung.de
4 June 2014; revised 11 July 2014; accepted 15 Julysome homeopathic remedies. The current difficulty in
formulating a plausible working mechanism for homeopa-
thy is the main point of concern for sceptics of homeo-
pathy.1e4 Positive effects of homeopathy in human
clinical trials are often disregarded as placebo effects,
self-healing or regression to the mean by skeptics.3,4
Systematic reviews and meta-analyses play an important
role in the ongoing debate between supporters and sceptics
of homeopathy3,5e10 (a list of hitherto published reviews in
the field of Homeopathy can be found in the online
supporting material).
In evidence-based medicine, a systematic review of
randomised and controlled clinical trials, including a
meta-analysis of the summarised data, is considered the
highest grade of evidence with regard to a given medicinal
intervention. A meta-analysis is a quantitative summary of
the outcomes of two or more primary research studies that
have been carried out on the same topic. By statistical pool-
ing of data, a meta-analysis increases confidence in the di-
rection and magnitude of effect size by including a greater
total number of patients than each of the original studies
alone. The compilation of such a systematic review is pre-
ceded by a rigorous literature search for appropriate publi-
cations. In conventional medicine, several specialised
databases exist. The problem for review authors in the field
of homeopathy is that the conventional databases usually
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Homeoponly contain a fraction of the relevant studies.11,12 This is
mostly due to the fact that many of these studies have
been published without having gone through a “peer
review process”. The peer review process strives to
maintain standards of quality and to ensure the credibility
of scientific publications.13,14 During peer review of a
manuscript submitted to a scientific journal, independent
reviewers from the same field (“peers”) judge its intrinsic
quality, offering improvements as may be appropriate,
and recommend to the journal editor whether it should be
published or not. Publications in books, conference
proceedings or reports are usually not covered by
conventional databases. Moreover, several studies in
homeopathy are published in languages other than
English, French or Spanish, which can be an additional
obstacle for inclusion in conventional databases.
The need for a publicly available and reliable source of
information in the field of homeopathy clinical research
was thus identified and the CORE-Hom database project
was launched (http://www.carstens-stiftung.de/core-hom).
It was created by the Karl und Veronica Carstens-
Stiftung (www.carstens-stiftung.de) in collaboration with
the Homeopathy Research Institute (http://www.
homeoinst.org/). CORE-Hom is the abbreviation for “Clin-
ical Outcome REsearch in Homeopathy”. The interface of
CORE-Hom is in English and access to CORE-Hom is free
after a cost-free registration. Here we present the first over-
view of the CORE-Hom database, describing the search
functionalities and providing some statistics.Figure 1 Database interface of CORE-Hom. Box A contains detailed s
including a full text search option (one single word) in the bibliographical su
search for main publications, only. The sliders () in Box C apply (whenma
reviews by Shang,3 Linde5,15 and Dean.16 Box E defines the output style
CR = clinical relevance, IV = Internal validity (Jadad Score).19
athyDescriptionof thedatabaseinterface
The database interface (Figure 1) enables not only
searching by the standard bibliographical data (author
name, peer review status) but also through a number of
characteristics of the studies themselves. The latter include
the medical indication, the field of disease, the study design
(Parallel/Crossover, Sequence generation and Blinding),
the prescribed remedies and trial controls, and whether
intention-to-treat analysis was used or not. Search for these
items is limited to fixed drop-down lists. In contrast to this,
the interface for the two fields “Indication” and “Author” is
different from the other search items in the sense that the
user may enter any combination of characters and the
drop-down list is filtered according to the matching data
entries.
In addition, the database offers the possibility of filtering
database entries based on the scientific quality ratings of
past systematic reviews. Currently the database offers the
ratings assigned by Shang et al.,3 Linde et al.,5,15 and
Dean et al.16
Moreover it is possible to filter for main publications
only (see Figure 1, item “B”). This adjustment excludes
(for example) all second publications, re-analyses, transla-
tions and interim-publications of cohort studies from the
subsequent search result.
An extra field allows full text searches in the “reference
field”. The “reference field” comprises the author informa-
tion, the title, the publication date and the journal informa-
tion.
The logical operator for combining search parameters is
always AND.tudy information, while Box C contains the bibliographical data,
mmary (authors, title, journal information). The checkbox B allows
nually activated) filters based on the results of the three prominent
of search results. OR = Odd ratio, MQ = Methodological quality,
Main
publications
Main
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Figure 2 Breakdown of database entries between peer review status, sequence generation and main publications. Main publications: trials
after exclusion of re-analyses and second publications (e.g. in other languages) etc. RCT = Randomised controlled trials (including quasi-
randomised controlled trials). N-RCT = Non-randomised trials. * Unclear or not determined yet.
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file card style. Information is provided on the search fields
mentioned above and on bibliographic data. Brief sum-
maries of the study results are included. The data sets
contain links to the abstracts of the publications, if avail-
able. Importantly, a given publication may describe the re-
sults of a numbers of trials. In order to distinguish these,
such trials are differentiated from one another by Roman
numerals (e.g. “Aabel 2000i”, “Aabel 2000ii”). Different
publications by the same first author in the same year are
discernible by lowercase letters (e.g. “Bell 2004a”, “Bell
2004b”, “Bell2004c”).
A special feature is the grouping of publications in the
search results. This feature enables the user to retrieve all
publications of certain authors on the same topic. If, for
example, several publications belong to the same cohort
study or if they are re-analyses of older publications,
such attributes will be clearly visible. Similarly, another
category indicates the number of review articles the indi-
vidual studies was included in. Clicking on the hyperlinks
(“Cohort”, “Reanalysis”, “Reviewed”) in the search result
opens a new window that summarises all trials in a given
cohort group/review/grouping of main publication and sub-
sequent re-analyses. The grouping “Reanalysis” also in-
cludes identical second publications, conference
abstracts, theses or translations into other languages.Table 1 Medicinal fields and their number of assigned trials
Field n Field n
Respiratory tract disorders 126 Cancer 21
Traumatic injuries 110 Ear disorders 18
Mental disorders 93 Other (rare) fields 16
Gynaecology and obstetrics 83 Eye disorders 14
Infections 76 Urology 9
Dermatology 68 Dentistry 9
Allergies 58 Toxicology 8
Neurology 57 Various indications 6
Primary care 53 Pain 6
Gastroenterology 53 Homeopathic
pathogenic trial
1
Musculoskeletal disorders 47 Safety 1
Rheumatology 33 Circulatory system 1
Cardiovascular system 33 Not assigned 26
Metabolism 22Databasecontent
In May 2014, the database held 1048 entries. At the time
of writing, the database is still being curated, although the
functionalities are completely operational. The high num-
ber of “unknown” items or missing numbers in the subse-
quent paragraphs is, to the most part, due to the
continuing but still incomplete assessment of some of the
characteristics of the publications. For example, for a given
study most of the characteristics might have been already
assessed while some of them still need to be assessed.
The peer reviewed part of the literature represents 352
trials in the database. 531 trials were non-peer reviewed,
whilst for 165 of them the peer review status is unknown
(either unclear or not determined yet).
475 of the listed records correspond to randomised,
controlled trials (RCTs). In 245 trials, no randomisation
procedure was applied. In 39 studies, sequence generationwas assigned as quasi-randomised; employing special
methods for patient allocation like “Minimisation”17,18 or
randomisation procedures that involve some systematic,
non-random approach like alternating allocation or
sequence generation based on the week of the month. In
summary, 514 trials either employed a randomised or
quasi-randomised design. After removal of secondary pub-
lications and re-analyses, 303 randomised or quasi-rando-
mised, controlled trials remain; 198 of these appeared in
peer reviewed journals and 101 in non-peer reviewed jour-
nals. In four randomised or quasi-randomised, controlled
trials no information on peer review status of the respective
journal was available. Figure 2 displays a breakdown of
studies between various parameters starting from peer re-
view status.
In 730 trials, the results were compared between study
group and control group(s) (205 without controls, 113 as
yet unassessed). 518 trials applied placebo controls, 163
used standard treatment as control and 42 used untreated
participants as controls. 33 studies applied a three-arm
design. 22 of these three-arm trials compared the homeo-
pathic treatment to standard treatment and placebo treat-
ment, nine to untreated control groups and placebo and
another two to standard treatment and untreated groups.
The majority of controlled trials applied parallel study de-
signs (n = 717) rather than cross-over study settings
(n = 58). 217 observational studies are included. Blinding
was conducted in single blinded (n = 53) or double blinded
manner (n = 474).Homeopathy
Table 2 Top ten of most often investigated substances/remedies
Substance/remedy n
Arnica montana 103
Traumeel 40
Rhus toxicodendron 19
Galphimia glauca 14
Sulphur 13
Nux vomica 13
Arsenicum album 12
Engystol 11
Vertigoheel 11
Pulsatilla pratensis 11
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HomeopTrials are grouped in 26 different therapeutic areas. Most
studies were performed in the field of “Respiratory tract
disorders” (n = 126), “Traumatic injuries” (n = 110) and
“Mental disorders” (n = 93); see Table 1. In six trials, a
number of clinical indications were investigated at the
same time (categorised as “Various”). Studies investigating
rather rare condition were grouped together (“Other”;
n = 16). Separate from this category “Other”, we created
two further categories to which more trials are expected
to be assigned after completion of the data assessment
and inclusion of future studies (“Safety” n = 1; “Homeo-
pathic pathogenetic trial” n = 1).
In total, 276 different substances were prescribed in pa-
tient treatment. Arnica montana is the remedy most often
used (n = 103), followed by the complex preparation
Traumeel (n = 40) and Rhus toxicodendron (n = 19).
The ten most often administered remedies are listed in
Table 2. Among these, three trademarked remedies of the
company Heel are found (Traumeel, Engystol, Verti-
goheel). Trademarked complex remedies were not broken
down into their constituent parts. In 370 trials, more than
five different remedies were used, denoted “Various” in
the field “Homeopathic remedy”.
In 265 trials, fixed remedies (“clinical homeopathy”5) or
complex remedies (n = 214) were used and in 34 trials rem-
edies were selected according to the principles of isopathy.
In 343 studies, remedy prescription was individualised
(often termed “classical homeopathy”5).Perspectives
The CORE-Hom database is still being curated. It is
already in use, there are however studies which have not
yet been indexed completely. In some studies, indexing is
as yet quite rudimentary. Currently, most gaps exist for
the number of included and analysed patients. In addition,
some of the mentioned special features have been only
partially implemented to date (e.g. assignment to previous
review articles). Having gone over the current limitations
of the database, it is worth mentioning that we concentrated
on the 198 peer reviewed RCTs as they would be of most
interest to the majority of users. Therefore, most of these
have already been fully characterized in the database.
The interface of CORE-Hom is likely to undergo some
modifications in future in order to make its use more
comfortable and self-explanatory. Moreover, the databaseathywill also be accessible via the homepage of the Homeopa-
thy Research Institute (http://www.homeoinst.org/).
The most recent review of randomised controlled trials of
homeopathy in humans, whichwas supervised by the British
Homeopathic Association (http://www.britishhomeopathic.
org/evidence/), identified 263 randomised, controlled trials
in the peer reviewed literature (n = 164) and non-peer re-
viewed literature (n = 99).12 In contrast to this, the CORE-
Hom database lists 198 randomised (or quasi-randomised)
trials in peer reviewed and 101 trials in non-peer reviewed
publications (sum = 299; only main publications consid-
ered). The differences in numbers are due to the continuous
updating of CORE-Hom database (new publications) and
slightly different criteria for the definition of ’main publica-
tion’. All studies listed in Mathie et al. 2013 12 are indexed
completely in CORE-Hom. As soon as they are available,
the quality ratings of this systematic review programme
will also be included in the database.
CORE-Hom is curated and regularly updated by the
Carstens-Stiftung in collaboration with the Homeopathy
Research Institute: new publications are added, missing in-
formation is completed and errors in the existing records
are corrected. Users of the databases are encouraged to
inform the Karl and Veronica Carstens-Stiftung about
any publications missing from the database or any errors
of content they might identify.
The database was designed with the strongest scientific
rigour in mind, to offer researchers and the general public
a solid foundation from which to assess the quality of ho-
meopathy randomised controlled trials, as well as the
many clinical fields to which they relate. In future, we
believe the database will be a valuable asset for scientists,
health professionals and patients alike.
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